Citius Oncology, Inc. (CTOR) vs Nutriband Inc. (NTRB)
A side-by-side comparison of Citius Oncology, Inc. and Nutriband Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTOR
Citius Oncology, Inc.
$0.87HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT
NTRB
Nutriband Inc.
$6.68HealthcareDelayed quote: Oct 6, 2026, 1:51 PM EDT
Total return — CTOR vs NTRB
growth of $100 · dividends reinvested · last 2yCTOR -92.4% (-72.4%/yr)NTRB -0.1% (-0.1%/yr)NTRB compounded faster over this window
Log scale — wide-divergence pair
CTOR NTRB
CTOR vs NTRB: by the numbers
- •NTRB is the larger company ($81M vs $81M market cap).
- •Both run net losses; NTRB's is the smaller (-430.43% vs -648.32% net margin).
Metrics side by side
Valuation
| Metric | CTOR | NTRB |
|---|---|---|
| Forward P/E | 8.69 | 4.25 |
| P/S ratio | 11.38 | 50.16 |
| P/B ratio | 2.00 | 15.24 |
Profitability
| Metric | CTOR | NTRB |
|---|---|---|
| Gross margin | 0.00% | 33.14% |
| Operating margin | 0.00% | -408.41% |
| Net margin | -648.32% | -430.43% |
| ROE | -114.06% | -130.67% |
| ROIC | -88.72% | -126.99% |
Growth (annualized)
| Metric | CTOR | NTRB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 3.12% |
| Total return CAGR (5Y) | N/A | 6.67% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.